首页 >
法规速递
-
Page: Allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations - Scientific guideline-2024/2/23
2024-03-11查看详情 > -
Page: Non-clinical and clinical evaluation of antiviral medicinal products and monoclonal antibodies for the prevention and treatment of COVID-19 - Scientific guideline-2024/2/22
2024-03-11查看详情 > -
Document: Reflection paper on investigation of pharmacokinetics in the obese population - Scientific guideline-2024/2/14
2024-03-11查看详情 > -
Page: Evaluation of medicinal products indicated for treatment of bacterial infections - Scientific guideline-2024/2/9
2024-03-11查看详情 > -
Page: ICH Q14 Analytical procedure development - Scientific guideline-2024/1/26
2024-03-11查看详情 > -
Page: Maximum residue limit (MRL) evaluation for biological substances - Scientific guideline-2024/1/26
2024-03-11查看详情 > -
Page: Clinical evaluation of medicinal products intended for treatment of hepatitis B - Scientific guideline-2024/1/26
2024-02-05查看详情 > -
Page: Maximum residue limit (MRL) evaluation for biological substances - Scientific guideline-2024/1/26
2024-02-05查看详情 > -
Page: ICH Q14 Analytical procedure development - Scientific guideline-2024/1/26
2024-02-05查看详情 > -
Page: Product-specific bioequivalence guidance-2024/1/15
2024-02-05查看详情 >